山羊抗大鼠IgG H&L (HRP polymer) (ab214882)
Key features and details
- Goat Anti-Rat IgG H&L (HRP polymer)
- Conjugation: HRP polymer
- Host species: Goat
- Isotype: IgG
- Suitable for: Immunoelectrophoresis, IHC-P
Related conjugates and formulations
概述
-
产品名称
山羊抗大鼠IgG H&L (HRP polymer)
参阅全部 IgG 二抗 -
宿主
Goat -
靶标种属
Rat -
特异性
Based on IEP, ab214882 reacts with heavy (gamma) chains on rat IgG, light chains on all rat immunoglobulins. No cross-reactivity is observed to non-immunoglobulin rat serum proteins, IgG from human or mouse. -
经测试应用
适用于: Immunoelectrophoresis, IHC-Pmore details -
免疫原
Full length protein corresponding to Rat IgG. (Purified Rat IgG, whole molecule).
-
偶联物
HRP polymer
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Store at +4°C. -
存储溶液
Preservative: 0.1% Proclin 300
Constituents: 1% BSA, 98% PBS -
Concentration information loading...
-
纯度
Affinity purified -
纯化说明
ab214882 was affinity purified using solid phase Rat IgG. Purity >95% by SDS-PAGE. -
克隆
多克隆 -
同种型
IgG -
研究领域
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab214882于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
Immunoelectrophoresis |
Use at an assay dependent concentration.
This product is provided in a pre-diluted, ready-to-use format. Incubate 150 µl per slide for 1 hour. |
|
IHC-P | (2) |
Use at an assay dependent concentration.
|
说明 |
---|
Immunoelectrophoresis
Use at an assay dependent concentration. This product is provided in a pre-diluted, ready-to-use format. Incubate 150 µl per slide for 1 hour. |
IHC-P
Use at an assay dependent concentration. |
图片
实验方案
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
数据表及文件
-
SDS download
-
Datasheet download
文献 (3)
ab214882 被引用在 3 文献中.
- Kireeva G et al. Modeling of Chemoperfusion vs. Intravenous Administration of Cisplatin in Wistar Rats: Adsorption and Tissue Distribution. Molecules 25:N/A (2020). PubMed: 33076418
- Li X et al. Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners. Nat Commun 11:6364 (2020). PubMed: 33311474
- Nakashima H et al. Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma. Clin Cancer Res 24:2574-2584 (2018). PubMed: 29511029